期刊
JOURNAL OF PROTEOME RESEARCH
卷 9, 期 12, 页码 6265-6273出版社
AMER CHEMICAL SOC
DOI: 10.1021/pr100547y
关键词
inflammatory bowel disease; dextran sulfate sodium; CD1 mice; OPLS; metabolomics; chemometrics
资金
- Genome Alberta
- Alberta Department of Advanced Education and Technology
Quantitative profiling of a large number of metabolic compounds is a promising method to detect biomarkers in inflammatory bowel diseases (IBD) such as ulcerative colitis (UC) We induced an experimental form of UC in mice by treatment with dextran sulfate sodium (DSS) and characterized 53 serum and 69 urine metabolites by use of H-1 NMR spectroscopy and quantitative (targeted ) analysis to distinguish between diseased and healthy animals Hierarchical multivariate orthogonal partial least-squares (OPLS) models were developed to detect and predict separation of control and DSS treated mice DSS treatment resulted in weight loss, colonic inflammation, and increase in myeloperoxidase activity Metabolomic patterns generated from the OPLS data clearly separated DSS-treated from control mice with a slightly higher predictive power (Q(2)) for serum (0 73) than urine (0 71) During DSS colitis creatine, carnitine, and methylamines increased in urine while in serum, maximal increases were observed for ketone bodies, hypoxanthine, and tryptophan Antioxidant metabolites decreased in urine whereas in serum, glucose and Krebs cycle intermediates decreased strongly Quantitative metabolic profiling of serum and urine thus discriminates between healthy and DSS-treated mice Analysis of serum or urine seems to be equally powerful for detecting experimental colitis, and a combined analysis offers only a minor improvement
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据